M C Chawarski

Summary

Affiliation: Yale University
Country: USA

Publications

  1. doi request reprint Lifetime ATS use and increased HIV risk among not-in-treatment opiate injectors in Malaysia
    Marek C Chawarski
    Yale University School of Medicine, New Haven, CT 06519, USA
    Drug Alcohol Depend 124:177-80. 2012
  2. pmc Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial
    M C Chawarski
    Department of Psychiatry, Yale University School of Medicine, 34 Park St, New Haven, CT 06519, USA
    Drug Alcohol Depend 115:237-9. 2011
  3. doi request reprint Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial
    M C Chawarski
    Yale University School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA
    Drug Alcohol Depend 94:281-4. 2008
  4. ncbi request reprint Community reinforcement approach for combined opioid and cocaine dependence. Patterns of engagement in alternate activities
    R S Schottenfeld
    CMHC SAC, Room S 205, 34 Park Street, New Haven, CT 06519, USA
    J Subst Abuse Treat 18:255-61. 2000
  5. doi request reprint Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial
    Richard S Schottenfeld
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Lancet 371:2192-200. 2008
  6. ncbi request reprint Heroin dependence and HIV infection in Malaysia
    Marek C Chawarski
    Yale University School of Medicine, Department of Psychiatry, New Haven, CT, USA
    Drug Alcohol Depend 82:S39-42. 2006
  7. ncbi request reprint Linking process and outcome in the community reinforcement approach for treating cocaine dependence: a preliminary report
    Michael V Pantalon
    Department of Psychiatry, Yale University School of Medicine, APT Foundation, Inc, New Haven, Connecticut, USA
    Am J Drug Alcohol Abuse 30:353-67. 2004
  8. pmc The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
    Am J Addict 19:53-8. 2010
  9. pmc Brief intervention for hazardous and harmful drinkers in the emergency department
    GAIL D'ONOFRIO
    Section of Emergency Medicine, Yale University School of Medicine, New Haven, CT 06519, USA
    Ann Emerg Med 51:742-750.e2. 2008
  10. doi request reprint Research- and community-based clinicians' attitudes on treatment manuals
    Declan T Barry
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Am J Addict 17:145-8. 2008

Detail Information

Publications20

  1. doi request reprint Lifetime ATS use and increased HIV risk among not-in-treatment opiate injectors in Malaysia
    Marek C Chawarski
    Yale University School of Medicine, New Haven, CT 06519, USA
    Drug Alcohol Depend 124:177-80. 2012
    ..We investigated risk factors for HIV associated with use of amphetamine type stimulants (ATS) among not-in-treatment opiate injectors in Malaysia...
  2. pmc Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial
    M C Chawarski
    Department of Psychiatry, Yale University School of Medicine, 34 Park St, New Haven, CT 06519, USA
    Drug Alcohol Depend 115:237-9. 2011
    ..Manual-guided behavioral drug and HIV risk reduction counseling is feasible to deliver by the trained MMT nursing personnel and appears to be a promising approach for improving the efficacy of standard MMT services in China...
  3. doi request reprint Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial
    M C Chawarski
    Yale University School of Medicine, Department of Psychiatry, New Haven, CT 06519, USA
    Drug Alcohol Depend 94:281-4. 2008
    ....
  4. ncbi request reprint Community reinforcement approach for combined opioid and cocaine dependence. Patterns of engagement in alternate activities
    R S Schottenfeld
    CMHC SAC, Room S 205, 34 Park Street, New Haven, CT 06519, USA
    J Subst Abuse Treat 18:255-61. 2000
    ..g., planned pleasurable events or parenting activities) was associated with abstinence suggests that the planning and reinforcement of specific nondrug-related social, vocational, and recreational activities is a crucial component of CRA...
  5. doi request reprint Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial
    Richard S Schottenfeld
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Lancet 371:2192-200. 2008
    ....
  6. ncbi request reprint Heroin dependence and HIV infection in Malaysia
    Marek C Chawarski
    Yale University School of Medicine, Department of Psychiatry, New Haven, CT, USA
    Drug Alcohol Depend 82:S39-42. 2006
    ..This, study evaluated drug use and other HIV risk behaviors and their association with HIV and other infectious diseases in heroin-dependent subjects enrolled in a clinical trial of drug abuse treatment in Muar, Malaysia...
  7. ncbi request reprint Linking process and outcome in the community reinforcement approach for treating cocaine dependence: a preliminary report
    Michael V Pantalon
    Department of Psychiatry, Yale University School of Medicine, APT Foundation, Inc, New Haven, Connecticut, USA
    Am J Drug Alcohol Abuse 30:353-67. 2004
    ..The findings of this preliminary study suggest the importance of monitoring both mechanistic and interpersonal processes during CRA treatment of cocaine dependence...
  8. pmc The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
    Am J Addict 19:53-8. 2010
    ..35%, p = .001). We conclude that both baseline and in-treatment cocaine use is associated with worse treatment outcomes in patients receiving office-based buprenorphine/naloxone and may benefit from targeted interventions...
  9. pmc Brief intervention for hazardous and harmful drinkers in the emergency department
    GAIL D'ONOFRIO
    Section of Emergency Medicine, Yale University School of Medicine, New Haven, CT 06519, USA
    Ann Emerg Med 51:742-750.e2. 2008
    ..To determine the efficacy of emergency practitioner-performed brief intervention for hazardous/harmful drinkers in reducing alcohol consumption and negative consequences in an emergency department (ED) setting...
  10. doi request reprint Research- and community-based clinicians' attitudes on treatment manuals
    Declan T Barry
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Am J Addict 17:145-8. 2008
    ..Findings suggest that community SUD clinicians are already familiar with and have positive attitudes toward manuals, but specific subgroups have concerns that should be addressed...
  11. doi request reprint Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
    Am J Addict 17:116-20. 2008
    ..Serum transaminases remained stable from baseline. No serious adverse events related to treatment occurred. We conclude that select opioid-dependent patients exhibit moderate levels of retention in primary care office-based treatment...
  12. ncbi request reprint Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence
    Richard S Schottenfeld
    Department of Psychiatry, Yale University School of Medicine, 34 Park St, Rm S204, New Haven, CT 06519, USA
    Am J Psychiatry 162:340-9. 2005
    ..This study compares effects of buprenorphine and methadone and evaluates the efficacy of combining contingency management with maintenance treatment for patients with co-occurring cocaine and opioid dependence...
  13. pmc Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
    J Subst Abuse Treat 35:87-92. 2008
    ..We conclude that primary-care-based buprenorphine/naloxone treatment is associated with decreased drug-related HIV risk, but additional efforts may be needed to address sex-related HIV risk when present...
  14. pmc Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients
    Brent A Moore
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    J Gen Intern Med 22:527-30. 2007
    ..Prescription opioid dependence is increasing, but treatment outcomes with office-based buprenorphine/naloxone among these patients have not been described...
  15. pmc Patient satisfaction with primary care office-based buprenorphine/naloxone treatment
    Declan T Barry
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519 1187, USA
    J Gen Intern Med 22:242-5. 2007
    ..Factors associated with satisfaction among patients receiving primary care-based buprenorphine/naloxone are unknown...
  16. ncbi request reprint A trial of integrated buprenorphine/naloxone and HIV clinical care
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Clin Infect Dis 43:S184-90. 2006
    ..We investigated the feasibility and efficacy of integrating buprenorphine, along with 2 levels of counseling, into HIV clinical care...
  17. ncbi request reprint Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06520, USA
    N Engl J Med 355:365-74. 2006
    ..The optimal level of counseling and frequency of attendance for medication distribution has not been established for the primary care, office-based buprenorphine-naloxone treatment of opioid dependence...
  18. ncbi request reprint Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms
    Marek C Chawarski
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    J Subst Abuse Treat 29:307-12. 2005
    ..Measures of withdrawal symptoms or illicit opioid use were not associated with buprenorphine dose, formulation, or plasma buprenorphine levels...
  19. pmc Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence
    Marek C Chawarski
    Yale University School of Medicine, New Haven, CT 06519, USA
    J Subst Abuse Treat 33:411-5. 2007
    ..3% were brought back attached to the skin) and that weekly sweat testing is less sensitive than weekly urine testing in detecting opiate use, suggest limited utility of sweat patch testing in outpatient clinical settings...
  20. ncbi request reprint New challenges and opportunities in managing substance abuse in Malaysia
    Mahmud Mazlan
    Substance Abuse Center, Muar, Malaysia
    Drug Alcohol Rev 25:473-8. 2006
    ..Despite these recent advances, treatments for amphetamine-type stimulant abuse or dependence are underdeveloped, and diversion of agonist medications is an emerging concern...

Research Grants5

  1. Brief Introductory Therapy for Opioid Dependence
    Marek Chawarski; Fiscal Year: 2006
    ..Data obtained from the study will be used to evaluate the effect size of the differences between CBAT and MDC to determine the necessary sample size for a Stage II study comparing CBAT and MDC. ..
  2. Behavioral Drug and HIV Risk Reduction Counseling with MMT in China
    Marek C Chawarski; Fiscal Year: 2010
    ..Evidence-based counseling that is efficacious in reducing HIV risks and drug use and is feasible to provide with MMT will greatly improve the public health benefits of disseminating MMT in China and elsewhere in the world. ..
  3. Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia
    Marek C Chawarski; Fiscal Year: 2010
    ....